Quantification of HCV RNA levels and detection of core antigen in donations before seroconversion
- 28 August 2002
- journal article
- research article
- Published by Wiley in Transfusion
- Vol. 42 (8) , 1032-1036
- https://doi.org/10.1046/j.1537-2995.2002.00161.x
Abstract
BACKGROUND: Detection of HCV during the window phase of infection before seroconversion is important in blood screening. HCV RNA levels were measured before seroconversion and compared with HCV core antigen and anti‐HCV detection.STUDY DESIGN AND METHODS: A total of 41 plasma samples from 17 US plasmapheresis donors and one English National Blood Service donor in the window phase before seroconversion of HCV infection were tested for the presence of anti‐HCV, HCV RNA, and HCV core antigen.RESULTS: HCV RNA levels between 5.4 × 102and 3.4 × 107IU per mL were measured. HCV core antigen was detected in 11 of 18 donors at the same time point as RNA was detected.CONCLUSIONS: A wide range of HCV RNA levels can be detected during the seronegative window phase of HCV infection. HCV core antigen can be used to detect HCV infection during the window phase of infection.Keywords
This publication has 13 references indexed in Scilit:
- Performance Characteristics of the COBAS Amplicor Hepatitis C Virus (HCV) Monitor, Version 2.0, International Unit Assay and the National Genetics Institute HCV Superquant AssayJournal of Clinical Microbiology, 2002
- Efficacy of a hepatitis C virus core antigen enzyme‐linked immunosorbent assay for the identification of ‘window‐phase’ blood donationsVox Sanguinis, 2001
- Efficacy of HCV core antigen detection during the preseroconversion periodTransfusion, 2000
- Detection of Hepatitis C Core Antigen in the Antibody Negative ‘Window’ Phase of Hepatitis C InfectionVox Sanguinis, 2000
- Validation of HCV-NAT Assays and Experience with NAT Application for Blood Screening in GermanyBiologicals, 1999
- Establishment of the First International Standard for Nucleic Acid Amplification Technology (NAT) Assays for HCV RNAVox Sanguinis, 1999
- Optimisation and evaluation of a quantitative cherniluminescent polymerase chain reaction assay for hepatitis C virus RNAJournal of Virological Methods, 1995
- Improved Detection of Anti‐HCV in Post‐Transfusion Hepatitis by a Third‐Generation ELISAVox Sanguinis, 1995
- Improvement of HCV genome detection with "short" PCR productsThe Lancet, 1991
- Nucleotide sequence of the brome mosaic virus genome and its implications for viral replicationJournal of Molecular Biology, 1984